BTTX vs. UPHL, ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, and TOIIW
Should you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.
Better Therapeutics vs.
UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, community ranking, dividends and institutional ownership.
Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users.
UpHealth has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500.
56.1% of UpHealth shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Better Therapeutics has lower revenue, but higher earnings than UpHealth.
In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.
Summary
Better Therapeutics beats UpHealth on 4 of the 6 factors compared between the two stocks.
Get Better Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Better Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:BTTX) was last updated on 2/22/2025 by MarketBeat.com Staff
